1-7 of 7
Donald Northfelt
Close
Sort by
Journal Articles

Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination

Michael T. Francisco, Adrienne E. Kaufman, Donald Northfelt, Leslie Padrnos, Allison C. Rosenthal, Jennifer Andres, Jill Adamski, Theresa Kinard, John Camoriano
Journal: Blood
Blood (2021) 138 (Supplement 1): 4218.
https://doi.org/10.1182/blood-2021-151964
Published: 2021
Journal Articles

Relationship of Area-Level Socioeconomic Status Indicators and Nutritional Anemias: Analysis of Folate, Vitamin B12, and Iron Deficiencies

Miguel Gonzalez Velez, MD, Carolyn Mead-Harvey, MS, Heidi E. Kosiorek, MS, Yael Kusne, MD PhD, Leyla Bojanini, MD, Candido E. Rivera, MD, Donald Northfelt, MD, Chung-II Wi, MD, Leslie Padrnos, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-142897
Published: 2020
Journal Articles

Duration Matters: Impact of Time from Diagnosis on Symptoms in Patients with Hematologic Malignancies

Leslie Padrnos, MD, Heidi Kosiorek, MS, Robert M Bennett, III, Amylou Constance Dueck, PhD, Krisstina L. Gowin, DO, Robyn M. Scherber, MD, Holly L. Geyer, MD, Jeanne Palmer, MD, Donald Northfelt, MD, Joseph R Mikhael, MD FRCPC, MD, Nandita Khera, MD, Ruben A Mesa, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2162.
https://doi.org/10.1182/blood.V130.Suppl_1.2162.2162
Published: 2017
Journal Articles

PD-1 Blockade with Pembrolizumab in Relapsed Low Grade Non-Hodgkin Lymphoma

Wei Ding, MD PhD, Betsy Laplant, MS, Thomas E Witzig, MD, Patrick B Johnston, MD PhD, Joseph P Colgan, MD, Karen L Rech, MD, Jose F. Leis, MD PhD, Andrew L Feldman, MD, Rong He, MD, Grzegorz S Nowakowski, MD, Erik J Asmus, David J Inwards, MD, Luis Porrata, MD, Thomas M Habermann, MD, Yi Lin, MD PhD, Gita Thanarajasingam, MD, Nabila Nora Bennani, MD, Craig B. Reeder, MD, Donald Northfelt, MD, Jeanne Palmer, MD, Prashant Kapoor, MD, David S Viswanatha, MD, Stephen M Ansell, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4055.
https://doi.org/10.1182/blood.V130.Suppl_1.4055.4055
Published: 2017
Journal Articles

Living With Cancer: Assessing The Educational, Symptomatic, and Quality Of Life Impact Of a Comprehensive Patient Symposia On Cancer Patients

Leslie J Padrnos, M.D, Amylou Constance Dueck, PhD, Robert M. Bennett, III, Robyn M. Emanuel, MD, MPH, Ruben A. Mesa, MD, Donald Northfelt, MD, Joseph R. Mikhael, MD, Pamela Glassley, Rachel Stigge, Annette Aguirre
Journal: Blood
Blood (2013) 122 (21): 2955.
https://doi.org/10.1182/blood.V122.21.2955.2955
Published: 2013
Journal Articles

Phase I Trial of a Novel Combination of An HDAC Inhibitor (LBH589) and An mTOR Inhibitor (RAD001) in Lymphoid and Plasma Cell Malignancies

Shaji Kumar, MD, Joseph R. Mikhael, MD, Betsy R. LaPlant, Joseph P. Colgan, MD, David James Inwards, MD, Patrick B. Johnston, Kristina Laumann, Ivana N. Micallef, MD, Grzegorz S. Nowakowski, Stephen M. Ansell, M.D., Ph.D., Kelly Curtis, MD, Angela Dispenzieri, MD, Martha Q Lacy, MD, Jose F. Leis, MD, PhD, Donald Northfelt, MD, Craig B. Reeder, MD, James L. Slack, MD, Thomas E. Witzig, MD
Journal: Blood
Blood (2011) 118 (21): 2682.
https://doi.org/10.1182/blood.V118.21.2682.2682
Published: 2011
Journal Articles

A Phase 1b Clinical Trial of Dacetuzumab in Combination with Rituximab and Gemcitabine: Multiple Responses Observed in Patients with Relapsed Diffuse Large B-Cell Lymphoma.

Andres Forero-Torres, MD, Nancy L Bartlett, MD, Sunita D Nasta, MD, Donald Northfelt, MD, Anne Beaven, MD, Han Myint, FRCP, FRCPath, Nancy C Whiting, PharmD, BCOP, Jonathan G Drachman, MD, Craig H Moskowitz, MD
Journal: Blood
Blood (2009) 114 (22): 586.
https://doi.org/10.1182/blood.V114.22.586.586
Published: 2009